SCHEMBL6002524

SCHEMBL6002524

Cc1ccc(-n2c(=O)[nH]c3cc(NC4=C(Cl)C(=O)C(Nc5ccc6c(c5)[nH]c(=O)n6-c5ccc(C)cc5)=C(Cl)C4=O)ccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 3/20 0.43
NPC1 O15118 2/20 0.43
HTT P42858 2/20 0.43
RAB9A P51151 2/20 0.43
MITF O75030 1/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
TP53 P04637 3/20 0.43
HPGD P15428 1/20 0.43
DAO P14920 1/20 0.39
APP P05067 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KCNMA1 Q12791 1/20 0.37
MAPK1 P28482 1/20 0.36
MCL1 Q07820 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1639467 0.79 LMNA (0.45) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL7709585 0.78 ALDH1A1 (0.40) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL1640026 0.76 KMT2A (0.54) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL5718492 0.73 ALDH1A1 (0.50) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL5240740 0.72 MEN1 (0.62) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL11352988 0.70 DAO (0.60) KMT2AMEN1LMNAL3MBTL1HTT
SCHEMBL4098385 0.70 AURKA (0.56) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL6002035 0.69 KMT2A (0.55) KMT2AMEN1LMNAL3MBTL1MAPT
SCHEMBL14596923 0.66 KDM4E (0.61) KMT2AMEN1LMNAL3MBTL1NPC1
SCHEMBL5353986 0.65 MEN1 (0.64) KMT2AMEN1LMNAL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1120420-B1 Triphendioxazine compounds CLARIANT FINANCE BVI LTD (VG) 2006-01-11 EP disclosed
US-6617453-B1 Preparing these triphendioxazine compounds by a cyclization step conducted in the presence of manganese dioxide and concentrated sulphuric acid. CLARIANT FINANCE (BVI) LIMITED (VG) 2003-09-09 US disclosed
EP-0911337-B1 Process for the preparation of triphendioxazine compounds CLARIANT FINANCE BVI LTD (VG) 2003-02-26 EP disclosed
US-6355795-B1 PIGMENTS POSSESSING HIGH FASTNESS TO SOLVENTS, MIGRATION AND LIGHT, WHICH HAVE GOOD THERMAL STABILITIES AND HIGH TINTING POWER AND ARE ALSO EASILY DISPERSIBLE CLARIANT FINANCE (BVI) LIMITED (BV) 2002-03-12 US disclosed
EP-1120420-A2 New triphendioxazine compounds Clariant Finance (BVI) Limited (VG) 2001-08-01 EP disclosed
EP-1120421-A2 New triphendioxazine compounds Clariant Finance (BVI) Limited (VG) 2001-08-01 EP disclosed
US-6255482-B1 PREPARING CHLORINE-CONTAINING TRIPHENDIOXAZINE COMPOUNDS USEFUL AS PIGMENTS POSSESSING HIGH FASTNESS TO SOLVENTS, MIGRATION, AND LIGHT, WHICH HAVE GOOD THERMAL STABILITIES AND HIGH TINTING POWER CLARIANT FINANCE (BVI) LIMITED (VG) 2001-07-03 US disclosed
EP-0911337-A1 New triphendioxazine compounds Clariant Finance (BVI) Limited (VG) 1999-04-28 EP disclosed